Hygrovest Limited (UWC) AI Stock Analysis

• Market Cap: AU$9.24M
• Dividend Yield: N/A
• Average Volume (3M): 57.74K
• Price to Earnings (P/E): 39.6
• Beta (1Y): 0.81
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: AU
• Employees: N/A
• Sector: Financial
• Sector Strength: 70
• Industry: Asset Management
• EPS (TTM): 0.02
• Shares Outstanding: 205,326,860
• 10 Day Avg. Volume: 32,968
• 30 Day Avg. Volume: 57,743
• PEG Ratio: -0.13
• Price to Book (P/B): 0.50
• Price to Sales (P/S): 17.82
• P/FCF Ratio: 16.76
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 54 Neutral
• Price Target: AU$0.05 ▼(-23.33% Downside)
• Action: Reiterated Date: 03/03/26
• Date: Action: Reiterated 03/03/26

The score is driven mainly by solid financial resilience (no debt, stable equity) and improving 2025 fundamentals (positive net income and free cash flow), offset by weak technicals (below key moving averages, negative MACD and oversold momentum) and an operating profitability concern (still-negative EBITDA). Valuation is supportive due to a low P/E.

Positive Factors

Zero net debt / strong balance sheet

Reported zero total debt and a stable equity base materially lower financial risk and preserve flexibility. Over 2-6 months this durability matters: the company can fund operations or investments from equity/cash without refinancing pressure, improving resilience through downturns.

Cash generation turned positive in 2025

A shift to positive operating and free cash flow indicates improved underlying cash generation. If sustained, this reduces reliance on external capital, supports reinvestment into the business, and provides a foundation for consistent funding of growth and working capital needs.

Revenue growth and positive net income in 2025

Meaningful top-line growth and a return to net profitability signal improving business momentum. Over the medium term, continued revenue expansion combined with cost control could translate into sustainable earnings recovery and set the stage for eventual operating profitability.

Negative Factors

Persistent negative EBITDA

Despite revenue gains and net income, continued negative EBITDA shows core operating profitability remains weak. Without converting topline into positive operating earnings, the company may struggle to generate consistent operating cash and margins needed for scaling and investor confidence.

Volatile historical cash flows and earnings

Large swings in cash generation and periodic cash burn indicate execution and operational volatility. This inconsistency raises forecasting risk and may force conservative liquidity management, hindering strategic investments and making sustained recovery less certain.

Low returns on equity / subdued profitability

ROE remains modest despite improvement, implying capital is not yet being deployed efficiently. Over the medium term, the company must translate revenue growth into higher returns; failure to lift ROE suggests limited earning power from existing assets and slower value creation.

Hygrovest Limited Business Overview & Revenue Model

Company Description

Underwood Capital Limited operates as a specialist investment company. The company focuses on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and debt securities. The company was formerly known as Hygrovest Limited and changed its name to Underwood Capital Limited in December 2024. Underwood Capital Limited was incorporated in 2014 and is based in Sydney, Australia.

How the Company Makes Money

null

Hygrovest Limited Financial Statement Overview

Summary

Balance sheet strength (zero debt and stable equity base) supports resilience, but operating performance remains mixed: revenue improved and net income turned positive in 2025, while EBITDA is still negative and historical earnings/cash flows have been volatile. Cash flow improved to positive operating and free cash flow in 2025, but consistency is not yet proven.

Income Statement

Revenue has grown meaningfully in the latest annual period (2025 vs. 2024), and the company returned to positive net income in 2025 after losses in 2024 and 2023. Gross profit is strong relative to revenue, but operating profitability remains a key weakness: EBITDA is negative in both 2025 and 2024, and the business showed very large losses in 2023 (and materially worse in 2020). Overall, the earnings profile looks volatile with improving top-line momentum but still-challenged underlying operating performance.

Balance Sheet

The balance sheet is a clear strength: total debt is reported as zero across all shown annual periods, and equity remains substantial and stable (roughly $19M in 2023–2025) relative to total assets. Return on equity has improved from materially negative in 2023 to slightly positive in 2025, but the low level of returns suggests the asset base is not yet generating strong profitability. Net-net, low leverage reduces financial risk, though returns remain modest.

Cash Flow

Cash generation has improved sharply in the latest annual period: operating cash flow and free cash flow turned positive in 2025 after significant cash burn in 2024 and negative free cash flow in 2023 and 2020. That said, the prior-year drawdowns highlight volatility and execution risk, and the provided cash-flow-to-earnings style ratios are not informative (reported as 0.0), limiting visibility into cash earnings quality. Overall, the trajectory is improving but consistency is not yet proven.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2019	Jun 2018
Income Statement
Total Revenue	211.00K	540.00K	206.00K	187.00K	0.00	211.00K
Gross Profit	-4.02M	540.00K	206.00K	187.00K	-10.00K	-4.02M
EBITDA	3.86M	-808.00K	-844.00K	-1.58M	-42.89M	3.86M
Net Income	5.14M	243.00K	-131.00K	-3.98M	-40.08M	5.14M
Balance Sheet
Total Assets	65.04M	21.71M	21.98M	21.96M	45.62M	65.04M
Cash, Cash Equivalents and Short-Term Investments	64.44M	21.27M	21.73M	21.19M	42.29M	64.44M
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.29M	2.48M	2.68M	2.58M	1.37M	1.29M
Stockholders Equity	63.75M	19.23M	19.21M	19.38M	44.25M	63.75M
Cash Flow
Free Cash Flow	-10.03M	574.00K	-3.49M	-1.53M	-24.44M	-10.03M
Operating Cash Flow	-8.27M	574.00K	-3.49M	-1.53M	-24.44M	-8.27M
Investing Cash Flow	-91.16M	0.00	0.00	0.00	0.00	-91.16M
Financing Cash Flow	77.57M	-228.00K	-35.00K	-1.04M	-1.15M	77.57M

Hygrovest Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
VIT	57 Neutral	AU$25.18M	-12.06	7.64%	3.28%	0.13%	-12.90%
UWC	54 Neutral	AU$9.24M	39.60	1.25%	―	―	―

Hygrovest Limited Corporate Events

Underwood Capital Issues February 2026 Portfolio Performance Update

Underwood Capital Limited has released an update on the performance of its investment portfolio for February 2026, fulfilling its disclosure obligations under ASX Listing Rule 4.12. While specific performance figures were not disclosed in the announcement, the update signals continued transparency around the company’s strategy of pursuing capital growth through diversified equity and debt investments and provides stakeholders with assurance on ongoing portfolio oversight and governance.

The most recent analyst rating on (AU:UWC) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on Hygrovest Limited stock, see the AU:UWC Stock Forecast page.

Underwood Capital files half-year financials and Appendix 4D with ASX

Underwood Capital Limited has lodged its Appendix 4D and financial statements for the half year ended 31 December 2025 with the ASX, providing investors with updated insight into its financial performance and position. The release underscores the company’s ongoing mandate to deliver capital growth from listed and unlisted equities and debt securities, and offers stakeholders formal, regulator-aligned disclosure that will inform market assessment of its strategy and results.

The documentation filing marks a routine but important compliance step for the specialist investment company, ensuring transparency around portfolio outcomes and capital management over the period. For shareholders and potential investors, the half-year report serves as a key reference point for evaluating Underwood Capital’s execution against its investment objectives and its standing within the broader funds management sector.

The most recent analyst rating on (AU:UWC) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Hygrovest Limited stock, see the AU:UWC Stock Forecast page.

Underwood Capital Reports January 2026 Portfolio Performance

Underwood Capital Limited has reported the performance of its investment portfolio for January 2026, fulfilling its disclosure obligations under ASX Listing Rule 4.12. The update reflects the company’s ongoing focus on transparent reporting around the performance of its listed and unlisted equity and debt investments, which is central to its strategy of delivering capital growth to shareholders.

The announcement reiterates that UWC’s results and future performance remain subject to various assumptions and market risks beyond its control. While confirming its commitment to shareholder value through portfolio management, the company cautions investors against relying on any specific return expectations and clarifies that the release does not constitute an offer or solicitation to buy or sell its securities, particularly in the United States.

The most recent analyst rating on (AU:UWC) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Hygrovest Limited stock, see the AU:UWC Stock Forecast page.

Underwood Capital Reports December 2025 Portfolio Performance Update

Underwood Capital Limited has released its investment portfolio performance update for December 2025, providing investors with an overview of how its portfolio of listed and unlisted equities and debt securities fared over the month in line with disclosure requirements. The update underscores the company’s ongoing commitment to transparency around portfolio outcomes and risk, reinforcing its positioning as a specialist capital-growth manager for shareholders while highlighting that future performance remains subject to market and operational uncertainties.

The most recent analyst rating on (AU:UWC) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Hygrovest Limited stock, see the AU:UWC Stock Forecast page.